Status:
COMPLETED
Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm
Lead Sponsor:
AdventHealth
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
19-89 years
Phase:
NA
Brief Summary
This study will test two different needles for performing a biopsy of the pancreas during endoscopic ultrasound (EUS) procedures. Patients who are asked to participate in this study have a growth in t...
Detailed Description
Endoscopic Ultrasound-guided fine needle aspiration (EUS-FNA) can be performed using the 25, 22 or 19 gauge (G) needles. Randomized trials have shown that all three needles are safe and perform equall...
Eligibility Criteria
Inclusion
- All patients referred to Florida Hospital Endoscopy Unit for assessment of pancreatic mass lesions greater than 35 mm on computed tomography (CT) that require FNA.
Exclusion
- Age \< 19 years
- Unable to safely undergo EUS for any reason
- Coagulopathy (INR \>1.6, Prothrombin Time \>18secs, Thrombocytopenia \<80,000 cells/ml)
- Unable to consent
- Non-English speaking patients
- Participation in any other clinical trial (excluding registries or databases)
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01815606
Start Date
February 1 2013
End Date
December 1 2013
Last Update
August 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Hospital
Orlando, Florida, United States, 32803